Arun Kumar, PhD
Arun Kumar, PhD
Coalition for Epidemic Preparedness Innovations (CEPI)
Verified email at cepi.net - Homepage
Title
Cited by
Cited by
Year
The COVID-19 vaccine development landscape.
LT Thanh, Z Andreadakis, A Kumar, RR Gómez, S Tollefsen, M Saville, ...
Nature reviews. Drug discovery, 2020
10222020
Novel Platforms for the Development of a Universal influenza vaccine
A Kumar, TS Meldgaard, S Bertholet
Frontiers in immunology 9, 600, 2018
662018
Serodiagnosis of primary infections with human parvovirus 4, Finland
A Lahtinen, P Kivelä, L Hedman, A Kumar, A Kantele, M Lappalainen, ...
Emerging infectious diseases 17 (1), 79, 2011
452011
Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence
C Filippone, R Franssila, A Kumar, L Saikko, PE Kovanen, ...
PLoS One 5 (3), e9496, 2010
442010
Comparison of Th‐cell Immunity Against Human Bocavirus and Parvovirus B19: Proliferation and Cytokine Responses are Similar in Magnitude but More Closely Interrelated with …
A Kumar, C Filippone, A Lahtinen, L Hedman, M Söderlund‐Venermo, ...
Scandinavian journal of immunology 73 (2), 135-140, 2011
272011
Epidemiology of two human protoparvoviruses, bufavirus and tusavirus
E Väisänen, M Paloniemi, I Kuisma, V Lithovius, A Kumar, R Franssila, ...
Scientific reports 6, 2016
232016
T-helper cell-mediated proliferation and cytokine responses against recombinant Merkel cell polyomavirus-like particles
A Kumar, T Chen, S Pakkanen, A Kantele, M Söderlund-Venermo, ...
PLoS One 6 (10), e25751, 2011
222011
Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison
A Kumar, JE McElhaney, L Walrond, TD Cyr, S Merani, TR Kollmann, ...
Human Vaccines & Immunotherapeutics, 1-10, 2017
202017
Granzyme B mediated function of Parvovirus B19-specific CD4+ T cells
A Kumar, MF Perdomo, A Kantele, L Hedman, K Hedman, R Franssila
Clinical & translational immunology 4 (7), e39, 2015
192015
Trichodysplasia spinulosa-associated polyomavirus (TSV) and Merkel cell polyomavirus: correlation between humoral and cellular immunity stronger with TSV
A Kumar, A Kantele, T Järvinen, T Chen, H Kavola, M Sadeghi, K Hedman, ...
PLoS One 7 (9), e45773, 2012
162012
Developing vaccines against epidemic-prone emerging infectious diseases
V Bernasconi, PA Kristiansen, M Whelan, RG Román, A Bettis, SA Yimer, ...
Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 63 (1), 65-73, 2020
152020
Microsphere-based antibody assays for human parvovirus B19V, CMV and T. gondii
Y Wang, L Hedman, MF Perdomo, A Elfaitouri, A Bölin-Wiener, A Kumar, ...
BMC infectious diseases 16 (1), 8, 2016
152016
Expression and serological characterization of polyomavirus WUPyV and KIPyV structural proteins
K Kantola, M Sadeghi, MJ Ewald, B Weissbrich, T Allander, C Lindau, ...
Viral immunology 23 (4), 385-393, 2010
152010
B cells and functional antibody responses to combat influenza
G Lofano, A Kumar, O Finco, G Del Giudice, S Bertholet
Frontiers in immunology 6, 2015
122015
Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotype
M Recher, ML Karjalainen-Lindsberg, M Lindlöf, M Söderlund-Venermo, ...
Journal of Allergy and Clinical Immunology 133 (5), 1462-1465. e5, 2014
72014
Influenza Virus Vaccines and Immunotherapies
A Kumar, S Singh
Frontiers in immunology 6, 2015
52015
Visceral procaine blockade in buffaloes.
SS Hussain, A Kumar
Indian Veterinary Journal, 1984
11984
A study of traditional mid-wife (Dai) training programme in two primary health centres.
A Kumar
POPCEN news letter. Population Centre (Lucknow, India) 4 (2), 1, 1978
11978
Status Report on COVID-19 Vaccines Development
A Kumar, WE Dowling, RG Román, A Chaudhari, C Gurry, TT Le, ...
Current Infectious Disease Reports 23 (6), 1-12, 2021
2021
Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
G Sanyal, A Särnefält, A Kumar
npj Vaccines 6 (1), 1-9, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20